| Amgen (AMGN) |
United States |
$146.724B |
15.34 |
| Bristol Myers Squibb (BMY) |
United States |
$145.219B |
10.35 |
| CSL (CSLLY) |
Australia |
$95.499B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$83.961B |
11.16 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$62.055B |
28.86 |
| Illumina (ILMN) |
United States |
$59.111B |
81.30 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$57.139B |
20.27 |
| Moderna (MRNA) |
United States |
$52.622B |
0.00 |
| Biogen (BIIB) |
United States |
$41.567B |
7.38 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$34.547B |
13.76 |
| Seagen (SGEN) |
United States |
$33.607B |
88.47 |
| BeiGene (BGNE) |
Cayman Islands |
$32.554B |
0.00 |
| Genmab (GMAB) |
Denmark |
$28.231B |
33.39 |
| Genmab (GNMSF) |
Denmark |
$26.960B |
6.21 |
| BioNTech SE (BNTX) |
Germany |
$23.855B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$22.273B |
0.00 |
| Incyte (INCY) |
United States |
$20.564B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$19.449B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$19.373B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$18.067B |
68.51 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$17.090B |
24.43 |
| Guardant Health (GH) |
United States |
$16.202B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$15.771B |
104.68 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$14.926B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$13.733B |
87.82 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$13.180B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$12.237B |
27.55 |
| Repligen (RGEN) |
United States |
$11.414B |
161.87 |
| Mirati Therapeutics (MRTX) |
United States |
$10.706B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$9.457B |
0.00 |
| Adaptive Biotechnologies (ADPT) |
United States |
$9.165B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$9.018B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$8.696B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$8.272B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$8.268B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$8.124B |
0.00 |
| Novavax (NVAX) |
United States |
$7.792B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$7.648B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$7.510B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$7.322B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.614B |
44.42 |
| Halozyme Therapeutics (HALO) |
United States |
$6.421B |
296.88 |
| NeoGenomics (NEO) |
United States |
$6.139B |
1843.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$5.932B |
17.35 |
| Emergent Biosolutions (EBS) |
United States |
$5.833B |
19.14 |
| Certara (CERT) |
United States |
$5.695B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$5.565B |
18.42 |
| Vir Biotechnology (VIR) |
United States |
$5.401B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$5.369B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$5.269B |
0.00 |
| Eidos Therapeutics (EIDX) |
United States |
$4.762B |
0.00 |
| China Biologic Products (CBPO) |
China |
$4.664B |
30.23 |
| Arena Pharmaceuticals (ARNA) |
United States |
$4.459B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$4.289B |
0.00 |
| Insmed (INSM) |
United States |
$4.287B |
0.00 |
| Arvinas (ARVN) |
United States |
$4.083B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$3.999B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.928B |
142.19 |
| Reata Pharmaceuticals (RETA) |
United States |
$3.790B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$3.730B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.417B |
33.55 |
| I-Mab (IMAB) |
China |
$3.119B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$3.109B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.959B |
0.00 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$2.690B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$2.624B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$2.620B |
0.00 |
| Amarin (AMRN) |
Ireland |
$2.468B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.405B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$2.380B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$2.205B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$2.187B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.169B |
56.20 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.057B |
17.02 |
| Sangamo Therapeutics (SGMO) |
United States |
$2.049B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$2.008B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.959B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$1.925B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$1.889B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.866B |
0.00 |
| Viela Bio (VIE) |
United States |
$1.861B |
0.00 |
| NantKwest (NK) |
United States |
$1.847B |
0.00 |
| Vericel (VCEL) |
United States |
$1.824B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$1.786B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$1.728B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.717B |
0.00 |
| Precigen (PGEN) |
United States |
$1.695B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.626B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.597B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$1.562B |
0.00 |
| Heska (HSKA) |
United States |
$1.548B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.542B |
0.00 |
| Codexis (CDXS) |
United States |
$1.516B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.498B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.496B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$1.422B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$1.373B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.372B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.353B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$1.343B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$1.308B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.296B |
8.57 |
| Alector (ALEC) |
United States |
$1.285B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.267B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$1.253B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$1.208B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.186B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.157B |
0.00 |
| Mesoblast (MESO) |
Australia |
$1.114B |
0.00 |
| Athenex (ATNX) |
United States |
$1.073B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$1.028B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$1.010B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.992B |
0.00 |
| MiMedx (MDXG) |
United States |
$0.979B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.965B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.946B |
0.00 |
| Morphic Holding (MORF) |
United States |
$0.927B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.926B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$0.925B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.908B |
24.17 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.901B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.871B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.865B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.860B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.831B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.796B |
40.42 |
| MannKind (MNKD) |
United States |
$0.793B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.773B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.771B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.746B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.713B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.712B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$0.709B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.705B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.688B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.686B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.665B |
0.00 |
| Curis (CRIS) |
United States |
$0.652B |
0.00 |
| Agenus (AGEN) |
United States |
$0.650B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.640B |
35.94 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.639B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.608B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.608B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.587B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.581B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.578B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.564B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.563B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.558B |
75.44 |
| Dynavax Technologies (DVAX) |
United States |
$0.555B |
0.00 |
| Aquinox Pharmaceuticals (NLTX) |
United States |
$0.545B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.533B |
0.00 |
| Pandion Therapeutics (PAND) |
United States |
$0.532B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.525B |
0.00 |
| Geron (GERN) |
United States |
$0.518B |
0.00 |
| FORTE BIOSCIENC (FBRX) |
United States |
$0.501B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.483B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.480B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.480B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.477B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.456B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.448B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.439B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.437B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.433B |
0.00 |
| XOMA (XOMA) |
United States |
$0.426B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.426B |
20.05 |
| Puma Biotechnology (PBYI) |
United States |
$0.421B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.418B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.415B |
0.00 |
| Lineage Cell Therapeutics (LCTX) |
United States |
$0.414B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.402B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.393B |
9.99 |
| Verastem (VSTM) |
United States |
$0.372B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.371B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.363B |
0.00 |
| Athersys (ATHX) |
United States |
$0.362B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.357B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.351B |
0.00 |
| AMMO (POWW) |
United States |
$0.349B |
0.00 |
| NextCure (NXTC) |
United States |
$0.347B |
0.00 |
| Trevena (TRVN) |
United States |
$0.339B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.336B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.324B |
8.32 |
| Fortress Biotech (FBIO) |
United States |
$0.323B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.308B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.305B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.300B |
14.04 |
| ChromaDex (CDXC) |
United States |
$0.297B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.290B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.282B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.277B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.267B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.267B |
0.00 |
| IBio (IBIO) |
United States |
$0.266B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.264B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.254B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.253B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.240B |
0.00 |
| Cerecor (CERC) |
United States |
$0.231B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.230B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.229B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.221B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.221B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.216B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.210B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.209B |
0.00 |
| Exicure (XCUR) |
United States |
$0.202B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.197B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.195B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.195B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.194B |
0.00 |
| VolitionRX (VNRX) |
United States |
$0.193B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.188B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.187B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.182B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.180B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.177B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.176B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.167B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.165B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.161B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.159B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.157B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.155B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.154B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.153B |
316.50 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.152B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.152B |
0.00 |
| Prometic Life Sciences (LMNL) |
Canada |
$0.149B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.149B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.147B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.145B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.143B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.139B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.130B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.129B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.123B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.123B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.121B |
0.00 |
| Ecology Coatings (ABVC) |
United States |
$0.121B |
0.00 |
| AIT Therapeutics (XAIR) |
United States |
$0.119B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.118B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.116B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.116B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.113B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.111B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.108B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.105B |
0.00 |
| Aytu Bioscience (AYTU) |
United States |
$0.104B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.096B |
0.00 |
| Adocia (ADOCY) |
France |
$0.091B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.091B |
0.00 |
| Stealth BioTherapeutics (MITO) |
United States |
$0.090B |
43.00 |
| CytRx (CYTR) |
United States |
$0.089B |
0.00 |
| CollPlant Holdings (CLGN) |
Israel |
$0.082B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.074B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.073B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.071B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.069B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.067B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.066B |
0.00 |
| Celsion (CLSN) |
United States |
$0.065B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.062B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.060B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.058B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.056B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.056B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.055B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.054B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.054B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.054B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.053B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.052B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.052B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.050B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.048B |
0.00 |
| Chanticleer Holdings (SONN) |
United States |
$0.046B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.045B |
0.00 |
| Spherix (AIKI) |
United States |
$0.042B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.042B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.040B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.039B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.036B |
0.00 |
| PLANET GREEN HOLDINGS CORP (PLAG) |
China |
$0.030B |
0.00 |
| Neuralstem (SNCA) |
United States |
$0.024B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
| Cesca Therapeutics (THMO) |
United States |
$0.021B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.019B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.015B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.015B |
0.00 |
| BioPharmX (TMBR) |
United States |
$0.013B |
0.00 |
| CTD Holdings (CYTH) |
United States |
$0.010B |
0.00 |
| Enveric Biosciences (ENVB) |
United States |
$0.007B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.000B |
0.00 |
| Zai Lab (ZLAB) |
China |
$0.000B |
0.00 |
